Business of Medicine
Commentary
‘Difficult Patient’: Stigmatizing Words and Medical Error
Dr. F. Perry Wilson comments on the potential of stigmatized language in medical records to lead to missed diagnoses and poor outcomes.
Latest News
Working From Home: Doctors’ Options Are Not Limited to Classic Telemedicine
Remote patient monitoring, management of NPs and PAs and on-call phone consults are a few options of home-based roles.
Conference Coverage
How Medicare Reimbursement Trends Could Affect Breast Surgeries
A new study showed a decline in Medicare reimbursements for breast cancer surgery by more than 20% from 2003 to 2023.
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
Latest News
Are You Ready for AI to Be a Better Doctor Than You?
Several recent examples of AI-backed diagnoses have bested doctors’ accuracy in diagnoses, and many clinicians have expressed concern.
From the Journals
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
Latest News
EHR Copy and Paste Can Get Physicians Into Trouble
Physicians have lost hospital privileges and paid fines for copying and pasting information into EHRs, say sources.
Latest News
Medicine or Politics? Doctors Defend Their Social Activism
Many physicians are not only willing to stand up for what they believe in, but they see it as an essential part of their profession.
From the Journals
New Quality Measure Improves Follow-Up for CRC Screening
Field testing shows that this CRC screening tracker is “feasible, valid, and reliable.”
Feature
Oncology Practice and Lab to Pay $4 Million in Kickback Case
The DOJ claims payments for referring biopsies constituted illegal kickbacks under the Anti-Kickback Statute.
Feature
Prostate Cancer Tsunami Coming, Experts Caution
Expert suggests approaches for enabling earlier diagnosis of prostate cancer in men in low- to middle-income countries.